Navigation Links
ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents
Date:7/21/2014

SAN DIEGO, July 21, 2014 /PRNewswire/ -- An International Trade Commission (ITC) ruling issued Friday held that, despite a redesign of its iCH CPAP device, Taiwanese device manufacturer APEX continues to infringe ResMed patents in its humidification. ResMed (NYSE: RMD) is the innovation leader and pioneer in designing and manufacturing devices for the treatment of sleep-disordered breathing.

"Our research and development teams are constantly researching and improving designs to reach new levels of comfort, performance and efficacy," said David Pendarvis, ResMed chief administrative officer and global general counsel. "This result – and APEX's own expert – affirms that the superior quality and functionality generated by ResMed innovation cannot be duplicated."

The original ITC action filed by ResMed in March 2013 asserted patent infringement by four products: APEX iCH and XT Fit CPAP humidifiers, the WiZARD 220 full face mask, and the WiZARD 210 nasal mask.
In July 2013, APEX agreed to entry of an order prohibiting it from infringing ResMed's patents.  And as a result, APEX has been banned from selling infringing products in the United States. 

APEX then redesigned its products and sought a ruling that it had avoided ResMed's patents. In this new ruling, the full commission held that the APEX iCH humidifier continues to infringe.  As a result, APEX should continue to be banned from selling the iCH humidifier in the United States. The redesigned APEX XT Fit was found not to infringe. But APEX's own expert stated that the redesigned humidifiers compromised on functionality and performance.  The redesigned WiZARD 220 full face mask – which now has a fused elbow instead of the more desirable detachable elbow -- was found not to infringe on ResMed patents.  Again, APEX's expert noted that the redesigned masks sacrificed functional advantages present in the ResMed products.  Finally, APEX chose to withdraw its redesigned WiZARD 210 nasal mask from these proceedings, so the July 2013 order remains in place as to that product.

About ResMed:
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, COPD, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.Contacts: For News Media For InvestorsGretchen Griswold

Agnes LeeDirector, Global Corporate Communications

Senior Director, Investor RelationsO: 858-836-6789

O: 858-836-5971news@resmed.com

investorrelations@resmed.comLogo - http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-a


'/>"/>
SOURCE ResMed Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Third Circuit Rules in Mylans Favor Regarding Paroxetine Hydrochloride Extended-Release Tablets, Sending Mylans Breach of Contract Claim Against GSK to Trial
2. The Rockley Group and Content Rules Ink Deal to Extend Global Reach
3. Announcement Under Irish Takeover Rules Relevant Securities in Issue
4. 2013 Chinese Pharmaceutical Guidebook: Drug Registration Rules
5. Arizona Judge Rules That Arizona Medical Marijuana Law is Constitutional
6. EMD Seronos Redesigned Fertility Pen Available for Distribution in US
7. Upsher-Smith Introduces Newly Redesigned Corporate Website
8. Vicks Starry Night Humidifier Available Now in New Colors Exclusively at Babies"R"Us
9. Newly Published Survey Shows Drug Shortages Still Have Major Impact on Patient Care
10. Despite A Difficult Competitive Environment, Opportunities Can Still Be Found In The Growing US Trauma Fixation Device Market
11. Yaz Settlement Funding News: 10K Cases Still Not Settled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... 29, 2017 Center Point Clinical ... platform, announced today study results presented in two ... #AMCP2017, Managed Care and Specialty Pharmacy annual meeting ... in both posters demonstrated that pharmacist-led patient interventions during ... These factors are crucial to generating the robust and ...
(Date:3/28/2017)... This morning,s research on ... The Medicines Co. (NASDAQ: MDCO), Ironwood Pharmaceuticals Inc. ... Supernus Pharmaceuticals Inc. (NASDAQ: SUPN ). ... which is governed by the same governing framework ... industry are wholesalers, retailers, pharmacies, and benefit managers. Learn ...
(Date:3/28/2017)... ROCKVILLE, Md. , March 28, 2017 /PRNewswire/ ... dedicated to innovative therapeutics addressing cancer and other ... at the American Association for Cancer Research annual ... April 3 is entitled "Evaluation of ENMD-2076 ... and the second poster to be presented ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... 28, 2017 , ... Resoundant, Inc., the developer of ... Healthineers annual customer education symposium, a world-class learning conference that offers educational content ... - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , Innovations ...
(Date:3/28/2017)... NY (PRWEB) , ... March 28, 2017 , ... ... process management software and services, is proud to announce it has joined the ... professional association representing the interests of chronically ill, disabled, and dying Americans of ...
(Date:3/28/2017)... , ... March 28, 2017 , ... WHO: , Dr. ... Bark , WHAT: , Medical doctors and PhD scientists will speak to the press ... President Trump in support of an independent vaccine safety commission. , WHERE: , ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... relocated its corporate headquarters to a new, more expansive office space in order ... 2016, Qualidigm purchased a distressed office building in Wethersfield, Conn. located at 936 ...
(Date:3/28/2017)... Florida (PRWEB) , ... March 28, 2017 , ... The ... Corp to raise money to for the Toys for Tots Literacy Campaign at their ... budget in excess of $70 billion, the U.S. ranks at number 14 internationally in ...
Breaking Medicine News(10 mins):